Viewing StudyNCT00217477



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00217477
Status: COMPLETED
Last Update Posted: 2014-12-09
First Post: 2005-09-20

Brief Title: Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
Sponsor: Roswell Park Cancer Institute
Organization: Roswell Park Cancer Institute

Organization Data

Organization: Roswell Park Cancer Institute
Class: OTHER
Study ID: CDR0000441212
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Roswell Park Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Abbott INDUSTRY